, Tracking Stock Market Picks
Enter Symbol:
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

up 111.05 %

Regeneron Pharmaceuticals, Inc. (REGN) upgraded to Buy by Lazard

Posted on: Friday,  Jul 12, 2013  8:25 AM ET by Lazard

Lazard rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 07/12/2013, when the stock price was $254.91. Since
then, Regeneron Pharmaceuticals, Inc. has gained 111.05% as of 01/27/2016's recent price of $538.00.
If you would have followed this Lazard's recommendation on REGN, you would have gained 111.05% of your investment in 929 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/12/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -4.65 %
1 Month down  -2.74 %
3 Months down  -7.02 %
1 YTD up  5.75 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/7/2012 8:36 PM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy